Gas Exchange in Disease: Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Interstitial Lung Disease

被引:37
|
作者
Young, Iven H. [1 ,2 ]
Bye, Peter T. P. [1 ,2 ]
机构
[1] Royal Prince Alfred Hosp, Dept Resp & Sleep Med, Camperdown, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
关键词
VENTILATION-PERFUSION INEQUALITY; CHRONIC HYPERCAPNIC COPD; SKELETAL-MUSCLE CAPILLARITY; OXYGEN-INDUCED HYPERCAPNIA; BREATH DIFFUSING-CAPACITY; ACUTE RESPIRATORY-FAILURE; NITRIC-OXIDE INHALATION; ARTERIAL-BLOOD-GASES; MESSENGER-RNA LEVELS; NONINVASIVE VENTILATION;
D O I
10.1002/cphy.c090012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Ventilation-perfusion ((V) over dotA/(Q) over dot) inequality is the underlying abnormality determining hypoxemia and hypercapnia in lung diseases. Hypoxemia in asthma is characterized by the presence of low.(V) over dotA/(Q) over dot units, which persist despite improvement in airway function after an attack. This hypoxemia is generally attenuated by compensatory redistribution of blood flow mediated by hypoxic vasoconstriction and changes in cardiac output, however, mediator release and bronchodilator therapy may cause deterioration. Patients with chronic obstructive pulmonary disease have more complex patterns of (V) over dotA/(Q) over dot inequality, which appear more fixed, and changes in blood flow and ventilation have less benefit in improving gas exchange efficiency. The inability of ventilation to match increasing cardiac output limits exercise capacity as the disease progresses. Deteriorating hypoxemia during exacerbations reflects the falling mixed venous oxygen tension from increased respiratory muscle activity, which is not compensated by any redistribution of (V) over dotA/(Q) over dot ratios. Shunt is not a feature of any of these diseases. Patients with cystic fibrosis (CF) have no substantial shunt when managed according to modern treatment regimens. Interstitial lung diseases demonstrate impaired oxygen diffusion across the alveolar-capillary barrier, particularly during exercise, although (V) over dotA/(Q) over dot inequality still accounts for most of the gas exchange abnormality. Hypoxemia may limit exercise capacity in these diseases and in CF. Persistent hypercapnic respiratory failure is a feature of advancing chronic obstructive pulmonary disease and CF, closely associated with sleep disordered breathing, which is not a prominent feature of the other diseases. Better understanding of the mechanisms of hypercapnic respiratory failure, and of the detailed mechanisms controlling the distribution of ventilation and blood flow in the lung, are high priorities for future research. (C) 2011 American Physiological Society. Compr Physiol 1: 663-697, 2011.
引用
收藏
页码:663 / 697
页数:35
相关论文
共 50 条
  • [1] Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
    Atanasova, Kalina R.
    Reznikov, Leah R.
    [J]. RESPIRATORY RESEARCH, 2018, 19
  • [2] Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
    Kalina R. Atanasova
    Leah R. Reznikov
    [J]. Respiratory Research, 19
  • [3] Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease
    Choi, Joon Young
    Song, Jin Woo
    Rhee, Chin Kook
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (02) : 122 - 136
  • [4] Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer
    Mizuno, Satoko
    Takiguchi, Yuichi
    Fujikawa, Ayako
    Motoori, Ken
    Tada, Yuji
    Kurosu, Katsushi
    Sekine, Yasuo
    Yanagawa, Noriyuki
    Hiroshima, Kenzo
    Muraoka, Katsumi
    Mitsushima, Toru
    Niki, Noboru
    Tanabe, Nobuhiro
    Tatsumi, Koichiro
    Kuriyama, Takayuki
    [J]. RESPIROLOGY, 2009, 14 (03) : 377 - 383
  • [5] Cystic Lung Disease Misdiagnosed as Chronic Obstructive Pulmonary Disease (COPD)
    Shahzadi, M.
    Joyo, N.
    Aslam, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?
    Piccari, Lucilla
    Aguilar-Colindres, Ricardo
    Rodriguez-Chiaradia, Diego A.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (05) : 370 - 379
  • [7] A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
    Huntley, Christopher
    Fahim, Ahmed
    Owen, James
    Chohan, Paren
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [8] Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?
    Slats, Annelies
    Taube, Christian
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (01) : 57 - 71
  • [9] CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease
    Fernandez, Elena Fernandez
    De Santi, Chiara
    De Rose, Virginia
    Greene, Catherine M.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (06) : 483 - 492
  • [10] Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
    Mall, Marcus A.
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 : S177 - S185